Abiopharma

🔍 Wang Ying-Lang (Executive)

Company: TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 12,881 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 375,273.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By ESPP Trust | shares_owned_after: 6,445.00 | Footnotes: F2
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By LTI Trust | shares_owned_after: 10,581.00 | Footnotes: F3
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 1,135,529.00

Footnotes:

• F1: Represents Common Shares vested on September 1, 2026 in accordance with the issuer's Employee Restricted Stock Awards Rules.
• F2: Common Shares purchased and held under the issuer's Employee Stock Purchase Plan ("ESPP").
• F3: Represents Common Shares purchased by a trust with cash received under the issuer's Long-Term Incentive ("LTI") Bonus Plan, over which the filer has obtained investment control.